Skip to content
DataLookout
Menu

NCT00508443

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

StatusActive, Not Recruiting
PhasePhase 1/2
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 32 versions: 24 with changes below, 8 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
    • Eligibility criteria expanded, about 19 words
    • Publications: details revised at 2 of 2 entries
  2. Notable Primary and study completion dates: Oct 31, 2024 to Oct 31, 2026v27
  3. Notable Primary and study completion dates: Oct 31, 2022 to Oct 31, 2024v25
  4. Notable Primary and study completion dates: Oct 31, 2021 to Oct 31, 2022v23
  5. Notable Primary and study completion dates: Oct 31, 2020 to Oct 31, 2021v22
Show 18 earlier versionsHide 18 earlier versions
  1. Notable Primary completion date: Oct 2019 to Oct 31, 2020
    • Study completion date: Oct 2020 to Oct 31, 2020
    • Start date: Oct 2002 to Oct 25, 2002
    v21
  2. Notable Primary completion date: Oct 2018 to Oct 2019
    • Study completion date: Oct 2018 to Oct 2020
    v19
  3. Notable Primary completion date: Oct 2017 to Oct 2018
    • Study completion date: Oct 2018
    v18
  4. Notable Primary completion date: Oct 2016 to Oct 2017v17
  5. Notable Primary completion date: Oct 2015 to Oct 2016
    • Study site revised
    v16
  6. Notable Primary completion date: Oct 2014 to Oct 2015v15
  7. Notable Primary completion date: Oct 2013 to Oct 2014v14
  8. Notable Primary completion date: Oct 2012 to Oct 2013
    • Eligibility criteria shortened, about 4 words
    • Study description shortened, about 3 words
    v13
  9. Notable Primary completion date: Oct 2011 to Oct 2012v11
  10. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  11. Minor Eligibility criteria expanded, about 4 wordsv9
  12. Minor Study site revisedv8
  13. Notable Primary completion date: Oct 2010 to Oct 2011v7
  14. Notable Primary endpoint revised
    • Eligibility criteria revised
    • Secondary endpoints shortened, about 27 words
    v6
  15. Notable Primary completion date: Oct 2009 to Oct 2010
    • Secondary endpoints: details revised at 2 of 2 entries
    v5
  16. Minor Eligibility criteria revised
    • Study description expanded, about 3 words
    v4
  17. Notable Primary endpoint revised
    • Secondary endpoints revised (2)
    • Study description expanded, about 1 word
    v3
  18. Minor Primary completion date: Oct 2009
    • Interventions: Stereotactic Spine Radiotherapy (Procedure) to Radiation Therapy (Radiation)
    • Study arms: 0 to 1
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Patient Response (Pain Relief)
Timeframe: Baseline, 3, 6, 9, 12, 18, and 24 months, then every six months

Arms and interventions

Radiation TherapyExperimental

Radiation Therapy using CT-on-Rails or Trilogy procedure. Participants prescribed to receive 9 Gy x 3 so that a peripheral dose of 27 Gy is given to the tumor.

Radiation: Radiation Therapy

Sites

1 site in 1 country

  • University of Texas MD Anderson Cancer CenterHouston, Texas, United States